Who is Andrew von Eschenbach

Ranked #8,265 in Healthy Living, #141,229 overall

Andrew C. von Eschenbach, M.D.

The Food and Drug Administration regulates approximately one-fourth of the U.S. economy, including every day items like food, drugs, medical devices, and cosmetics. Andrew C. von Eschenbach, M.D., respected urologic surgeon and oncologist was at the helm until January 2009. As FDA Commissioner, Dr. von Eschenbach oversaw the country's foremost consumer protection and health agency, entrusted with the safety of products that account for more than 20% of consumer spending. The FDA has a tremendous responsibility and influences American daily life more than any other governmental agency.

Prior to his nomination to the FDA post, Andrew von Eschenbach was Director of the National Cancer Institute, appointed by President George W. Bush in 2002. At that time he was serving as Chief Academic Officer of the University of Texas M.D. Anderson Cancer Center in Houston.

Dr. von Eschenbach, himself a two-time cancer survivor, has an impressive resume as a key leader in the fight against cancer. In addition to more than 200 articles, books, and text chapters, he has also served as an editorial board member of several leading journals. His career as a cancer researcher spans more than three decades, and he remains optimistic that the suffering and death due to cancer can be eliminated in the foreseeable future.


Official portrait of Dr. Andrew C. von Eschenbach by James Tennison

Andrew von Eschenbach

Creative Commons License

Andrew von Eschenbach

A Few Facts Courtesy of Wikipedia

Andrew C. von Eschenbach (born October 30, 1941 in Philadelphia, Pennsylvania) was the Commissioner of the United States Food and Drug Administration from 2006-2009. He became acting Commissioner on September 26, 2005, after the resignation of his predecessor Lester Crawford, and was confirmed as Commissioner by the Senate on December 7, 2006. He was previously the 12th director of the National Cancer Institute. After graduating from St. Joseph's Preparatory School, Von Eschenbach received his bachelor of science in biology from St. Joseph's University in 1963 and his MD from Georgetown University School of Medicine in 1967. He did residencies at Pennsylvania Hospital in general surgery and urology and taught urology at the University of Pennsylvania School of Medicine. He served in the US Navy Medical Corps with the rank of lieutenant commander from 1968 to 1971.

Andrew von Eschenbach

One of the World's Most Influential People

In 2006, Time named him as one of the Time 100 "People Who Shape Our World," writing that as head of the FDA, which "wields enormous influence on American lives," von Eschenbach "could make a signal contribution to the public's health" by focusing on issues of diet and obesity in addition to drugs and disease.

100 People Who Shape Our World 

TIME Magazine's 100

The Lives and Ideas of the World's Most Influential People

At a gala evening honoring TIME Magazine's 100 People Who Shape Our World, the VIP guests began to arrive and alight on the red carpet. As shock-jock Howard Stern emerged from his limo, the crowd went wild. A similar round of cheers welcomed honoree Paul Simon. Moments later, Andrew von Eschenbach and his wife Madelyn were greeted with polite smiles and quizzical looks. Little did the crowd realize that this man, Commissioner of the FDA, had perhaps more of an affect on their daily lives than any other member of TIME's esteemed roster of influential people.

This anecdote was related by my sister-in-law, Madelyn, who happens to be married to Dr. Andrew C. von Eschenbach, or Andy as he is known to family and friends.


TIME Magazine Selects the 100 Most Influential People in the World
Photo Essay | An Evening With the TIME 100

TIME Magazine Honoree Andrew von Eschenbach and Wife Madelyn (2006) 

On the Subject of Cancer

Andrew von Eschenbach, M.D.

Our best weapon today to deal with cancer is to be able to find it early, at a time when we still can effectively apply treatment. And we have a variety of methods of early detection available to us. We have, for example, mammography for breast cancer, and colonoscopy for colon cancer, and PSA, or prostate specific antigen, for prostate cancer. Those tests give us the opportunity to determine whether there may or may not be a problem present, and that gives us the opportunity to make rational decisions as to what we may need to do about that problem.

As a two-time cancer survivor and a cancer specialist, I have witnessed patients struggle to find a solution for their disease and place their hope in an experimental drug. There is, and always must be, a pathway for such options. Nonetheless, allowing mass marketing and promotion of unproven therapies would have serious consequences: false hope and lack of real medical progress that could ultimately lead to control and cure of devastating illnesses.

Andrew von Eschenbach, M.D. 

The National Cancer Institute in the News

Recent News Headlines About the National Cancer Institute

Andrew von Eschenbach
Diet High in Fish May Help or Harm, New Study from Cancer Prevention Institute ...
In the United States, more than 240000 men are diagnosed annually with prostate cancer and about 33720 die from the disease, according to the National Cancer Institute. Only lung cancer kills more American men. According to the Prostate Cancer ...
In prostate cancer, other death risks may be higher
Mainly, they raise questions for future studies, said Dr. Anthony D'Amico, of the Dana-Farber Cancer Institute and Harvard Medical School in Boston. "This is a study of associations, and does not prove cause-and-effect.
Oral nutritional interventions improve nutritional intake and QOL in ...
... intake and improve some aspects of quality of life (QOL) in malnourished cancer patients or those who are at nutritional risk, but do not effect mortality, according to a study published February 15 in the Journal of the National Cancer Institute.
RainDance Technologies' Customers to Showcase Cancer Research Successes at ...
MARCO ISLAND, Fla., Feb 15, 2012 (BUSINESS WIRE) -- RainDance Technologies, Inc., the Digital Biology(TM) Company, and customers including the National Cancer Institute (NCI), British Columbia Cancer Agency (BCCA), and Asuragen will highlight recent ...

The War on Cancer and Obesity

The Charlie Rose Show

powered by Youtube

The Charlie Rose Show

Andrew von Eschenbach

Loading

Andrew C. von Eschenbach 

Food & Drug Administration Press Releases

U.S. Food and Drug Administration

Andrew von Eschenbach
Loading Fetching RSS feed... please stand by

Food & Drug Administration Commissioner Andrew von Eschenbach 

On the Food & Drug Administration

FDA Commissioner Andrew von Eschenbach

For over 100 years, FDA has been recognized and praised as the gold standard of regulation throughout the world. Being given the opportunity to lead the Agency at this time, it is my responsibility to continue the excellent work of my predecessors and ensure that the Agency is equipped to handle the challenges of today and the future. The world is experiencing a rapid expansion of scientific knowledge and globalization that will have dramatic impacts on the industries and products that we regulate. The Agency must be equipped with the expertise and infrastructure to meet emerging challenges, such as: foodborne disease outbreaks, intentional or unintentional; evaluation of complex drugs and biologics brought about by emerging progress in molecular biology; the potential for pandemic flu; and medical devices bioengineered, miniaturized, and increasingly autonomous in evaluating and modulating our state of health.

FDA is working hard to ensure the safety and security of food, in collaboration with our Federal, state, local, and international food safety partners, and with consumers, industry, and academia. As a result of this effective collaboration, the American food supply continues to be among the safest in the world. Although we have made progress, much remains to be done. The recent incidents of contaminated food and animal feed demonstrate the challenges we face and the need to move toward a food safety and security system that is even more proactive and strategic, with a field force that is trained and equipped to focus on the challenges of today and tomorrow.

The FDA in the News

Recent News Headlines About the Food & Drug Administration

Andrew von Eschenbach
FDA probes rise in counterfeit drugs
"We do know there are counterfeits continuing to try and make their way onto the US supply chain," said Connie Jung, an associate director in the Food and Drug Administration's office of drug security. The FDA announced Tuesday it is investigating fake ...
FDA finds trace amounts of lead in 400 lipsticks
By Tara Meyer, KUSA A study by the Food and Drug Administration found 400 lipsticks on the market tested positive for lead. However, the lead found is at a low enough level to not cause a serious health risk. The least contaminated lipstick was Wet n' ...
AHF Challenges FDA Move to Fast Track Gilead's 'HIV Prevention' Drug Linked to ...
LOS ANGELES, Feb 15, 2012 (BUSINESS WIRE) -- AIDS Healthcare Foundation (AHF), the nation's largest HIV/AIDS nonprofit medical provider, today expressed its disappointment and dismay at the Food and Drug Administration's (FDA) decision to grant an ...
Inquiry widens into FDA's monitoring of whistleblowers' e-mail
By Lisa Rein A probe of the Food and Drug Administration's e-mail surveillance of its employees widened Wednesday as the independent federal agency representing whistleblowers opened an investigation. The FDA secretly monitored the private e-mail ...

August 1, 2006

Democratic Senators Hillary Rodham Clinton and Maria E. Cantwell announced they would block Andrew von Eschenbach's nomination as permanent FDA commissioner because of the department's failure to act on the application by Barr Pharmaceuticals to sell "Plan B" contraceptive pills over-the-counter. They ultimately voted for his nomination.

Secretary of State Hillary Rodham Clinton and Dr. Andrew von Eschenbach 

Thanks For Visiting

Andrew von Eschenbach

submit

Squidoo Lenses by Kim Giancaterino

Top 10 Squidoo Lenses Listed by Rank

Loading Fetching RSS feed... please stand by

Who is Andrew von Eschenbach?

KimGiancaterino's Bio

Who is Andrew von Eschenbach? was created by Kim Giancaterino on September 11, 2007. This Squidoo page is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License.

Andrew von Eschenbach
Loading

Creative Commons License

This License Applies to All Lenses Created by Kim Giancaterino

Loading
Feeling creative? Create a Lens!

A Call to Action 

by Geoffrey E. Moore, Foreword by Andrew von Eschenbach, M.D.

A Call to Action

Amazon Price: $1.40 (as of 02/15/2012)Buy Now

Nomination of Andrew von Eschenbach and Paul DeCamp 

United States Congress Senate Committee

NOMINATION OF ANDREW VON ESCHENBACH and PAUL DeCAMP

Amazon Price: $13.71 (as of 02/15/2012)Buy Now

Commissioners of the Food and Drug Administration 

by Hephaestus Books